Trials & Triumphs
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
The White Space Problem: Why Clinical Trials Still Take 16+ Months to Start
Today, I’d love to talk about the time gap between protocol design and the moment a clinician can enroll a patient in a clinical trial, also known as…
Jun 19
•
Zina Sarif
1
Share this post
Trials & Triumphs
The White Space Problem: Why Clinical Trials Still Take 16+ Months to Start
Copy link
Facebook
Email
Notes
More
May 2025
Why Drug Development Slowed Down (And What Can Be Done About It) - Part 1
Part 1: When Drug Development Moved Fast and Changed the World
May 16
•
Zina Sarif
1
Share this post
Trials & Triumphs
Why Drug Development Slowed Down (And What Can Be Done About It) - Part 1
Copy link
Facebook
Email
Notes
More
1
How MoonLake Turned Merck's Shelved Asset Into a $15B Breakthrough
Merck shelved it. Moonlake licensed it. Now it’s a $15B nanobody on the brink of reshaping inflammatory disease.
May 3
•
Zina Sarif
Share this post
Trials & Triumphs
How MoonLake Turned Merck's Shelved Asset Into a $15B Breakthrough
Copy link
Facebook
Email
Notes
More
April 2025
Designing Clinical Trials for the Wellness Economy
Digital Biomarkers in the age of e-PROs
Apr 25
•
Zina Sarif
4
Share this post
Trials & Triumphs
Designing Clinical Trials for the Wellness Economy
Copy link
Facebook
Email
Notes
More
A Theory of Site Engagement, Investigators Relationship Infrastructure, and the Future of Clinical Development Platforms
Let’s start from the beginning — what is a CRM?
Apr 18
•
Zina Sarif
1
Share this post
Trials & Triumphs
A Theory of Site Engagement, Investigators Relationship Infrastructure, and the Future of Clinical Development Platforms
Copy link
Facebook
Email
Notes
More
Why Commercial Teams Obsess Over HCP Data—And What ClinOps Must Learn
Why do we track HCP relationships obsessively in sales—but leave site engagement to spreadsheets and guesswork in R&D?
Apr 11
•
Zina Sarif
Share this post
Trials & Triumphs
Why Commercial Teams Obsess Over HCP Data—And What ClinOps Must Learn
Copy link
Facebook
Email
Notes
More
How I Think About CRMs, Yendou, and Building Blue Categories
journal entry - 27th march 2025
Apr 4
•
Zina Sarif
Share this post
Trials & Triumphs
How I Think About CRMs, Yendou, and Building Blue Categories
Copy link
Facebook
Email
Notes
More
March 2025
Is Bill Anderson Going DOGE on Bayer?
Picture this: a Texan tornado tearing through the hallowed halls of Bayer—the German giant that’s been churning out aspirin and agrochemicals since the…
Mar 28
•
Zina Sarif
Share this post
Trials & Triumphs
Is Bill Anderson Going DOGE on Bayer?
Copy link
Facebook
Email
Notes
More
The Weaponization of Drugs: The Age of Pharmaceutical Geopolitics
Once, the idea of a lifesaving drug doubling as a geopolitical weapon would have been dismissed as science fiction.
Mar 21
•
Zina Sarif
2
Share this post
Trials & Triumphs
The Weaponization of Drugs: The Age of Pharmaceutical Geopolitics
Copy link
Facebook
Email
Notes
More
February 2025
PharmaTech Deals: When Wins Turn to Dust
Failing your way to mastery
Feb 28
•
Zina Sarif
Share this post
Trials & Triumphs
PharmaTech Deals: When Wins Turn to Dust
Copy link
Facebook
Email
Notes
More
January 2025
Marketplaces Aren’t for Clinical Research
The Story behind the first Site Engagement CRM for Clinical Research
Jan 31
•
Zina Sarif
Share this post
Trials & Triumphs
Marketplaces Aren’t for Clinical Research
Copy link
Facebook
Email
Notes
More
Trials & Triumphs: Merging Two Worlds
I used to think startups were all about vision and strategy.
Jan 17
•
Zina Sarif
Share this post
Trials & Triumphs
Trials & Triumphs: Merging Two Worlds
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
